Brief: BioRestorative Therapies Announces SBIR Phase I Grant To Explore The Therapeutic Effects Of ThermoStem Targeting Polycystic Ovary Syndrome As Indication
Dec 6 (Reuters) - BioRestorative Therapies Inc BRTX.O :
* BIORESTORATIVE THERAPIES ANNOUNCES SBIR PHASE I GRANT TO
EXPLORE
THE THERAPEUTIC EFFECTS OF THERMOSTEM® TARGETING POLYCYSTIC
OVARY SYNDROME AS AN INDICATION
Source text for Eikon: ID:nGNX6N5dZ8
Further company coverage: BRTX.O
Recent news on Biorestorative Therapies
See all newsBioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM